NASCEND

The New Paradigm of Care for NAS
Overview
Raised: $12,447
Rolling Commitments ($USD)
09/04/2023
$207
22
2016
Healthcare & Pharmaceuticals
HealthTech
B2C
High
Low
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$83,183 |
$145,783 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-288,758 |
$-191,024 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$125,245 |
$408,032 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$140,958 |
$424,025 |
Short-Term Debt |
$130,566 |
$176,573 |
Long-Term Debt |
$497,321 |
$523,543 |
Total Liabilities |
$627,887 |
$700,116 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual